AUXYDIAG HEALTH CARE FRANCE : revenue, balance sheet and financial ratios

AUXYDIAG HEALTH CARE FRANCE is a French company founded 14 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in LE BAN-SAINT-MARTIN (57050), this company of category PME shows in 2021 a revenue of 9 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - AUXYDIAG HEALTH CARE FRANCE (SIREN 534881446)
Indicator 2021 2017 2016
Revenue 8 576 € 48 177 € 38 595 €
Net income -8 737 € -18 675 € -47 361 €
EBITDA 3 129 € 8 639 € -8 589 €
Net margin -101.9% -38.8% -122.7%

Revenue and income statement

In 2021, AUXYDIAG HEALTH CARE FRANCE achieves revenue of 9 k€. Revenue is declining over the period 2016-2021 (CAGR: -26.0%). Significant drop of -82% vs 2017. After deducting consumption (0 €), gross margin stands at 9 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 3 k€, representing 36.5% of revenue. Positive scissor effect: EBITDA margin improves by +18.6 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Net income is negative at -9 k€ (-101.9% of revenue), which will impact equity.

Revenue (2021) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

8 576 €

Gross margin (2021) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

8 576 €

EBITDA (2021) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

3 129 €

EBIT (2021) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-8 153 €

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-8 737 €

EBITDA margin (2021) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

36.5%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 85%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 19.7 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 29.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

85.465%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

45.654%

Cash flow / Revenue (2021) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

29.653%

Repayment capacity (2021) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

19.662

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

85.8%

Solvency indicators evolution
AUXYDIAG HEALTH CARE FRANCE

Sector positioning

Debt ratio
85.47 2021
2016
2017
2021
Q1: 0.0
Med: 8.28
Q3: 63.33
Average

In 2021, the debt ratio of AUXYDIAG HEALTH CARE FRANCE (85.47) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
45.65% 2021
2016
2017
2021
Q1: 16.51%
Med: 37.11%
Q3: 57.43%
Good +36 pts over 3 years

In 2021, the financial autonomy of AUXYDIAG HEALTH CARE FRANCE (45.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
19.66 years 2021
2016
2017
2021
Q1: 0.0 years
Med: 0.01 years
Q3: 1.79 years
Watch +54 pts over 3 years

In 2021, the repayment capacity of AUXYDIAG HEALTH CARE FRANCE (19.66) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 290.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 18.8x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

290.527

Interest coverage (2021) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

18.76

Liquidity indicators evolution
AUXYDIAG HEALTH CARE FRANCE

Sector positioning

Liquidity ratio
290.53 2021
2016
2017
2021
Q1: 139.0
Med: 204.34
Q3: 325.42
Good -7 pts over 3 years

In 2021, the liquidity ratio of AUXYDIAG HEALTH CARE FRANCE (290.53) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
18.76x 2021
2016
2017
2021
Q1: 0.0x
Med: 0.39x
Q3: 4.57x
Excellent +50 pts over 3 years

In 2021, the interest coverage of AUXYDIAG HEALTH CARE FRANCE (18.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 75 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1057 days. Excellent situation: suppliers finance 982 days of the operating cycle (retail model). Overall, WCR represents 784 days of revenue, i.e. 19 k€ to permanently finance. Over 2016-2021, WCR increased by +212%, requiring additional financing.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

18 678 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

75 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

1057 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2021) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

784 j

WCR and payment terms evolution
AUXYDIAG HEALTH CARE FRANCE

Positioning of AUXYDIAG HEALTH CARE FRANCE in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (21 transactions). This range of 381€ to 3 162€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2021
Indicative
0k€ 0k€ 3k€
865 € Range: 381€ - 3 162€
NAF 5 année 2021

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 21 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare AUXYDIAG HEALTH CARE FRANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about AUXYDIAG HEALTH CARE FRANCE

What is the revenue of AUXYDIAG HEALTH CARE FRANCE ?

The revenue of AUXYDIAG HEALTH CARE FRANCE in 2021 is 9 k€.

Is AUXYDIAG HEALTH CARE FRANCE profitable?

AUXYDIAG HEALTH CARE FRANCE recorded a net loss in 2021.

Where is the headquarters of AUXYDIAG HEALTH CARE FRANCE ?

The headquarters of AUXYDIAG HEALTH CARE FRANCE is located in LE BAN-SAINT-MARTIN (57050), in the department Moselle.

Where to find the tax return of AUXYDIAG HEALTH CARE FRANCE ?

The tax return of AUXYDIAG HEALTH CARE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does AUXYDIAG HEALTH CARE FRANCE operate?

AUXYDIAG HEALTH CARE FRANCE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.